VirtuS-Investment-Advisers

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
473
Total Value
367795360
Accession Number
0000019481-25-000015
Form Type
13F-HR
Manager Name
VirtuS-Investment-Advisers
Data Enrichment
95% identified
447 identified26 unidentified

Holdings

473 positions • $367.8M total value
Manager:
Search and click to pin securities to the top
Page 12 of 24
Krystal Biotech, Inc.
Shares:2.1K
Value:$372.9K
% of Portfolio:0.1% ($372.9K/$367.8M)
Tarsus Pharmaceuticals, Inc.
Shares:7.0K
Value:$360.9K
% of Portfolio:0.1% ($360.9K/$367.8M)
Travere Therapeutics, Inc.
Shares:20.0K
Value:$359.2K
% of Portfolio:0.1% ($359.2K/$367.8M)
DYNAVAX TECHNOLOGIES CORP
Shares:27.6K
Value:$358.4K
% of Portfolio:0.1% ($358.4K/$367.8M)
ImmunityBio, Inc.
Shares:118.1K
Value:$355.5K
% of Portfolio:0.1% ($355.5K/$367.8M)
BIOCRYST PHARMACEUTICALS INC
Shares:47.2K
Value:$354.3K
% of Portfolio:0.1% ($354.3K/$367.8M)
Immunocore Holdings plc
Shares:11.8K
Value:$351.5K
% of Portfolio:0.1% ($351.5K/$367.8M)
ACADIA PHARMACEUTICALS INC
Shares:20.8K
Value:$345.6K
% of Portfolio:0.1% ($345.6K/$367.8M)
Blueprint Medicines Corp
Shares:3.9K
Value:$343.2K
% of Portfolio:0.1% ($343.2K/$367.8M)
Legend Biotech Corp
Shares:10.1K
Value:$343.2K
% of Portfolio:0.1% ($343.2K/$367.8M)
RHYTHM PHARMACEUTICALS, INC.
Shares:6.4K
Value:$341.4K
% of Portfolio:0.1% ($341.4K/$367.8M)
Nuveen Churchill Direct Lending Corp.
Shares:20.0K
Value:$339.9K
% of Portfolio:0.1% ($339.9K/$367.8M)
ARDELYX, INC.
Shares:68.5K
Value:$336.4K
% of Portfolio:0.1% ($336.4K/$367.8M)
LIGAND PHARMACEUTICALS INC
Shares:3.2K
Value:$332.5K
% of Portfolio:0.1% ($332.5K/$367.8M)
530715AG6
Shares:
Value:$331.3K
% of Portfolio:0.1% ($331.3K/$367.8M)
Theravance Biopharma, Inc.
Shares:36.4K
Value:$324.9K
% of Portfolio:0.1% ($324.9K/$367.8M)
BIOGEN INC.
Shares:2.3K
Value:$316.2K
% of Portfolio:0.1% ($316.2K/$367.8M)
NEUROCRINE BIOSCIENCES INC
Shares:2.8K
Value:$313.3K
% of Portfolio:0.1% ($313.3K/$367.8M)
REGENERON PHARMACEUTICALS, INC.
Shares:486
Value:$308.2K
% of Portfolio:0.1% ($308.2K/$367.8M)
UNITED THERAPEUTICS Corp
Shares:994
Value:$306.4K
% of Portfolio:0.1% ($306.4K/$367.8M)